15d-prostaglandin J 2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria

European Journal of Pharmacology

Volumn 498, Issue 1-3, 2004, Pages 295-301

  Dugo, Laura ^a,b   Collin, Marika ^a   Cuzzocrea, Salvatore ^b   Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b U

Author keywords

(Rat); GW9662; Lipopolysaccharide; Peptidoglycan; Peroxisome proliferator activated receptor

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATINE KINASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HORMONE RECEPTOR BLOCKING AGENT; LIPOPOLYSACCHARIDE; MARKER; PEPTIDOGLYCAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PROSTAGLANDIN J2; SODIUM CHLORIDE; UNCLASSIFIED DRUG; 2-CHLORO-5-NITROBENZANILIDE; 9-DEOXY-DELTA-9-PROSTAGLANDIN D2; ANILIDE; DRUG DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN D2;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM ISOLATION; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEART INJURY; HEART RATE; KIDNEY DISEASE; LIVER DYSFUNCTION; LIVER INJURY; MALE; MULTIPLE ORGAN FAILURE; MUSCLE INJURY; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT; SEPTIC SHOCK; SKELETAL MUSCLE; STAPHYLOCOCCUS AUREUS; ANIMAL; BLOOD; CELL WALL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; KIDNEY; PATHOPHYSIOLOGY; WISTAR RAT;

ALANINE TRANSAMINASE; ANILIDES; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BLOOD PRESSURE; CELL WALL; CREATINE KINASE; CREATININE; ESCHERICHIA COLI; GAMMA-GLUTAMYLTRANSFERASE; HEART RATE; KIDNEY; LIPOPOLYSACCHARIDES; MALE; MULTIPLE ORGAN FAILURE; PEPTIDOGLYCAN; PPAR GAMMA; PROSTAGLANDIN D2; RATS; RATS, WISTAR; STAPHYLOCOCCUS AUREUS;

EID: 4444351825     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.07.074     Document Type: Article

References (38)

1. P. Aoun, D.G. Watson, and J.W. Simpkins Neuroprotective effects of PPAR-gamma agonists against oxidative insults in HT-22 cells Eur. J. Pharmacol. 472 2003 65 71
2. A. Atrih, P. Zollner, G. Allmaier, and S.J. Foster Structural analysis of Bacillus subtilis 168 endospore peptidoglycan and its role during differentiation J. Bacteriol. 178 1996 6173 6183
3. A.E. Baue The multiple organ or system failure syndrome Pathophysiology of Shock, Sepsis, and Organ Failure 1993 Springer Verlag Berlin 1004 1018
4. A.C. Bendixen, N.K. Shevde, K.M. Dienger, T.M. Willson, C.D. Funk, and J.W. Pike L-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1 Proc. Natl. Acad. Sci. U. S. A. 98 2001 2443 2448
5. R.J. Burnett, D.C. Haverstock, E.P. Dellinger, H.H. Reinhart, J.M. Bohnen, O.D. Rotstein, S.B. Vogel, and J.S. Solomkin Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial Surgery 118 1995 716 721
6. M. Collin, and C. Thiemermann The PPAR-gamma ligand 15-deoxydelta12,14 prostaglandin J2 reduces the liver injury in endotoxic shock Eur. J. Pharmacol. 476 2003 257 258
7. P.R. Colville-Nash, S.S. Qureshi, D. Willis, and D.A. Willoughby Inhibition of inducible nitric oxide synthase by peroxisome proliferator- activated receptor agonists: correlation with induction of heme oxygenase 1 J. Immunol. 161 1998 978 984
8. S. Cuzzocrea, P.K. Chatterjee, E. Mazzon, L. Dugo, I. Serraino, D. Britti, G. Mazzullo, A.P. Caputi, and C. Thiemermann Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation Br. J. Pharmacol. 135 2002 496 510
9. S. Cuzzocrea, A. Ianaro, N.S. Wayman, E. Mazzon, B. Pisano, L. Dugo, I. Serraino, R. Di Paola, P.K. Chatterjee, M. Di Rosa, A.P. Caputi, and C. Thiemermann The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- prostaglandinJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat Br. J. Pharmacol. 138 2003 678 688
10. S.J. De Kimpe, M. Kengatharan, C. Thiemermann, and J.R. Vane The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure Proc. Natl. Acad. Sci. U. S. A. 92 1995 10359 10363
11. P.D. Drew, and J.A. Chavis The cyclopentone prostaglandin 15-deoxy-delta(12,14) prostaglandin J2 represses nitric oxide, tumour necrosis factor-alpha, and IL-12 production by microglial cells J. Neuroimmunol. 115 2001 28 35
12. W. Fischer Physiology of lipoteichoic acids in bacteria Adv. Microb. Physiol. 29 1988 233 302
13. S.J. Foster Analysis of the autolysins of Bacillus subtilis 168 during vegetative growth and differentiation by using renaturing polyacrylamide gel electrophoresis J. Bacteriol. 174 1992 464 470
14. M. Fu, J. Zhang, Y.Y. Lin, X. Zhu, T.M. Willson, and Y.E. Chen Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells Biochem. Biophys. Res. Commun. 294 2002 597 601
15. J.A. Hewett, P.A. Jean, S.L. Kunkel, and R.A. Roth Relationship between tumor necrosis factor-alpha and neutrophils in endotoxin-induced liver injury Am. J. Physiol. 265 1993 G1011 G1015
16. B. Hinz, K. Brune, and A. Pahl 15-Deoxy-delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism Biochem. Biophys. Res. Commun. 302 2003 415 420
17. A. Ianaro, A. Ialenti, P. Maffia, B. Pisano, and M. Di Rosa HSF1/hsp72 pathway as an endogenous anti-inflammatory system FEBS Lett. 499 2001 239 244
18. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
19. Y. Kawahito, M. Kondo, Y. Tsubouchi, A. Hashiramoto, D. Bishop-Bailey, K. Inoue, M. Kohno, R. Yamada, T. Hla, and H. Sano 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats J. Clin. Invest. 106 2000 189 197
20. K.M. Kengatharan, S. De Kimpe, C. Robson, S.J. Foster, and C. Thiemermann Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure J. Exp. Med. 188 1998 305 315
21. L.M. Leesnitzer, D.J. Parks, R.K. Bledsoe, J.E. Cobb, J.L. Collins, T.G. Consler, R.G. Davis, E.A. Hull-Ryde, J.M. Lenhard, L. Patel, K.D. Plunket, J.L. Shenk, J.B. Stimmel, C. Therapontos, T.M. Willson, and S.G. Blanchard Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662 Biochemistry 41 2002 6640 6650
22. A.G. Matlow, J.M. Bohnen, C. Nohr, N. Christou, and J. Meakins Pathogenicity of enterococci in a rat model of fecal peritonitis J. Infect. Dis. 160 1989 142 145
23. M.A. Parant, P. Pouillart, C. Le Contel, F.J. Parant, L.A. Chedid, and G.M. Bahr Selective modulation of lipopolysaccharide-induced death and cytokine production by various muramyl peptides Infect. Immun. 63 1995 110 115
24. V. Pasceri, H.D. Wu, J.T. Willerson, and E.T. Yeh Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators Circulation 101 2000 235 238
25. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
26. A. Rossi, G. Elia, and M.G. Santoro Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation Proc. Natl. Acad. Sci. U. S. A. 94 1997 746 750
27. H. Ruetten, G.J. Southan, A. Abate, and C. Thiemermann Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase Br. J. Pharmacol. 118 1996 261 270
28. M.G. Santoro Heat shock factors and the control of the stress response Biochem. Pharmacol. 59 2001 55 63
29. D.S. Straus, and C.K. Glass Cyclopentenone prostaglandins: new insights on biological activities and cellular targets Med. Res. Rev. 21 2001 185 210
30. C. Thiemermann Interactions between lipoteichoic acid and peptidoglycan from Staphylococcus aureus: a structural and functional analysis Microbes Infect. 4 2002 927 935
31. C. Thiemermann, H. Ruetten, C.C. Wu, and J.R. Vane The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase Br. J. Pharmacol. 116 1995 2845 2851
32. Y. Tsubouchi, Y. Kawahito, M. Kohno, K. Inoue, T. Hla, and H. Sano Feedback control of the arachidonate cascade in rheumatoid synoviocytes by 15-deoxy-delta(12,14)-prostaglandin J2 Biochem. Biophys. Res. Commun. 283 2001 750 755
33. J.E. Wang, P.F. Jorgensen, M. Almlof, C. Thiemermann, S.J. Foster, A.O. Aasen, and R. Solberg Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model Infect. Immun. 68 2000 3965 3970
34. N.S. Wayman, Y. Hattori, M.C. McDonald, H. Mota-Filipe, S. Cuzzocrea, B. Pisano, P.K. Chatterjee, and C. Thiemermann Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size FASEB J. 16 2002 1027 1040
35. M.P. Weinstein, J.R. Murphy, L.B. Reller, and K.A. Lichtenstein The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults: II. Clinical observations, with special reference to factors influencing prognosis Rev. Infect. Dis. 5 1983 54 70
36. G.M. Wray, S.J. Foster, C.J. Hinds, and C. Thiemermann A cell wall component from pathogenic and non-pathogenic gram-positive bacteria (peptidoglycan) synergises with endotoxin to cause the release of tumour necrosis factor-alpha, nitric oxide production, shock, and multiple organ injury/dysfunction in the rat Shock 15 2001 135 142
37. X. Zhang, J.M. Wang, W.H. Gong, N. Mukaida, and H.A. Young Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2 J. Immunol. 166 2001 7104 7111
38. B. Zingarelli, M. Sheehan, P.W. Hake, M. O'Connor, A. Denenberg, and J.A. Cook Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways J. Immunol. 171 2003 6827 6837